CFDE Data Portal | Search RRN3P1

	Label	Description
	RRN3P1 Gene (Entity type)	ENSG00000291066 - RRN3 pseudogene 1
	RRN3P1 associations Collection (Entity type)	Associations for RRN3P1_associations
	RRN3P1 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	GSE145195 PPP2R3B overexpression 0 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE216043 cisplatin 7 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE111247 temozolomide LN-308 0 v 6 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE48812 sulforaphane 2 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE198930 prunetin AGS 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE73573 KDM1B knockdown 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE155162 GSE155169 buparlisib 1 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS

RRN3P1

ENSG00000291066 - RRN3 pseudogene 1

RRN3P1 associations

Associations for RRN3P1_associations

RRN3P1 associations.tsv

A file from IDG as part of the Harmonizome project

GSE145195 PPP2R3B overexpression 0 v 1 human dn

A Gene Set from LINCS

GSE216043 cisplatin 7 v 0 human dn

A Gene Set from LINCS

GSE111247 temozolomide LN-308 0 v 6 human up

A Gene Set from LINCS

GSE48812 sulforaphane 2 v 5 human up

A Gene Set from LINCS

GSE198930 prunetin AGS 1 v 0 human dn

A Gene Set from LINCS

GSE73573 KDM1B knockdown 1 v 0 human dn

A Gene Set from LINCS

GSE155162 GSE155169 buparlisib 1 v 3 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.